(Q44338463)

2 December 2017

Treatment of adult T-cell leukemia-lymphoma by CHOP followed by therapy with antinucleosides, alpha interferon and oral etoposide (English)

1 reference

2 December 2017

1 reference

6

1 reference

2 December 2017

Caroline Besson

1

0 references

author name string

Gerard Panelatti

2

1 reference

2 December 2017

Christine Delaunay

3

1 reference

2 December 2017

Claire Gonin

4

1 reference

2 December 2017

Alain Brebion

5

1 reference

2 December 2017

Yves Plumelle

7

1 reference

2 December 2017

1 December 2002

1 reference

2 December 2017

1 reference

2 December 2017

43

1 reference

2 December 2017

12

1 reference

2 December 2017

2275-2279

1 reference

Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study

2 December 2017

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000039983

Human T-lymphotropic virus type I infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000039983

Effect of Strongyloides stercoralis infection and eosinophilia on age at onset and prognosis of adult T-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000039983

Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T-cell leukemia/lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000039983

Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000039983

Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia/lymphoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000039983

Successful treatment of a patient with adult T-cell leukemia by daily oral administration of low-dose etoposide. Decrease in the amount of HTLV-I proviral DNA revealed by the polymerase chain reaction method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000039983

Adult T-cell leukemia/lymphoma in Jamaica: 1986-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000039983

Adult T cell leukaemia: a review of established and new treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000039983

Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia/lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000039983

Treatment of Adult T-Cell Leukemia-Lymphoma with Zidovudine and Interferon Alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000039983

An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000039983

Long-term maintenance combination chemotherapy with OPEC/MPEC (vincristine or methotrexate, prednisolone, etoposide and cyclophosphamide) or with daily oral etoposide and prednisolone can improve survival and quality of life in adult T-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000039983

10.1080/1042819021000039983

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference